Emo/pop punk vets The Starting Line broke up after releasing their most adventurous album (2007’s Direction), which cut their trajectory short in a way that left a lot of us wondering what they ...
Emo and pop-punk veterans the Starting Line have mostly kept busy in recent years by playing the classics across various reunion tours, save for the three-song Anyways EP in 2016, but now they’re set ...
Ibrutinib shows similar real-world overall survival outcomes for high-risk and non-high-risk CLL/SLL patients, suggesting cytogenetic risk factors do not affect its efficacy. The study utilized a ...
The Starting Line may be getting older, but they’re still young at heart. To prove it, they’re releasing their first album in 18 years, aptly-titled Eternal Youth this fall. Today, they release new ...
Cardiff Oncology's phase 2 trial of onvansertib in mCRC shows promising preliminary data, with improved response rates in a dose-dependent manner. Onvansertib appears well tolerated and effective when ...
Data from the COMPEL trial support extending osimertinib (Tagrisso, AstraZeneca) therapy to patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who progress on first-line treatment ...
Tislelizumab, combined with chemotherapy, is now FDA-approved for first-line treatment of unresectable or metastatic ESCC with PD-L1 expression. The phase 3 RATIONALE-306 study demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback